Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation
Non-invasive Optical Medical Device for Monitoring and Detecting Peripheral Intravenous Infusion Sites for Infiltration and Extravasation in Subjects Receiving Continuous Fluids
1 other identifier
observational
139
1 country
1
Brief Summary
The purpose of this study to to monitor the peripheral intravenous (PIV) site on subjects receiving continuous IV fluids for infiltration and extravasation events. Infiltration is an indication that the PIV is leaking fluids outside of the vascular system. The study hypothesis is to demonstrate that changes in the optical signals of the non-invasive monitoring medical device will detect infiltration and extravasation events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 9, 2011
CompletedFirst Posted
Study publicly available on registry
November 22, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFebruary 20, 2012
November 1, 2011
6 months
November 9, 2011
February 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Test performance of optical device for monitoring intravenous infusion site for infiltration.
6 months
Eligibility Criteria
Subjects will be recruited from Cincinnati Children's Hospital Medical Center.
You may qualify if:
- signed consent
- patient age under 12
- PIV with continuous fluids
You may not qualify if:
- no consent
- patient age over 12
- PIV fluids not continuous
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ivWatch, LLClead
Study Sites (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Darcy Doellman, RN
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Sylvia Rineair, MSHA, BSN
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Neil Johnson, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Michael Spigarelli, MD, PhD
Children's Hospital Medical Center, Cincinnati
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2011
First Posted
November 22, 2011
Study Start
August 1, 2011
Primary Completion
February 1, 2012
Study Completion
February 1, 2012
Last Updated
February 20, 2012
Record last verified: 2011-11